Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-03 · accession 0001127602-24-028719 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-05 | 2024-12-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +8,000 | 118.1K | +7% | $0 |
| 2024-12-05 | 2024-12-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $51.51 | -2,028 | 114.1K | -2% | -$104.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | A | A | 4,000 | $0.00 | 116,099 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-03 | A | A | 4,000 | $0.00 | 118,071 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-03 | F | D | 2,028 | $51.51 | 114,071 | D | — | — |